Anson Funds Management’s Medtronic MDT Stock Holding History

Anson Funds Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-21,500	Closed	-$1.73M	–	174
2023 Q1	$1.73M	Buy	+21,500	New	+$1.75M	0.28%	75
2021 Q2	–	Sell	-10,000	Closed	-$1.18M	–	306
2021 Q1	$1.18M	Hold	10,000	–	–	0.14%	168
2020 Q4	$1.17M	Hold	10,000	–	–	0.24%	97
2020 Q3	$1.04M	Buy	+10,000	New	+$1M	0.56%	50

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Anson Funds Management's MDT Position: Q2 2023 in Review

Anson Funds Management sold out of Medtronic (MDT) in Q2 2023, closing a stake of 21,500 shares — an estimated $1.73M sold.

Anson Funds Management first reported a position in MDT in Q3 2020 and held it in 4 quarters. The position peaked at $1.73M in Q1 2023. 2,056 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

Anson Funds Management reported no remaining Medtronic position as of Q2 2023 after selling out during the quarter.
Anson Funds Management sold 21,500 Medtronic shares in Q2 2023, an estimated $1.73M.
Anson Funds Management first reported a position in Medtronic in Q3 2020 and held it in 4 quarters.
Anson Funds Management's Medtronic position peaked at $1.73M in Q1 2023.
2,056 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on Anson Funds Management's 13F filing for Q2 2023, filed 14 Aug 2023.